Cancer datasets and tissue pathways

The College's Datasets for Histopathological Reporting on Cancers are vital for standardising cancer reporting methods among pathologists. These datasets define the range of acceptable practice in handling pathology specimens, and enhance cancer diagnosis and treatment quality. 

Cancer datasets encompass structured collections of data related to cancer patients. Tissue pathways are instrumental in defining best practices when handling pathology specimens from patients who do not have cancer. These guidelines are pivotal in raising the bar for healthcare standards in pathology.

TNM 9 is to be implemented in most specialties for patients diagnosed on or after 1 January 2026. A full list of staging systems to be used (by specialty) is available in the Recommendations from the Recommendation on the use of tumour staging systems from the College’s Working Group on Cancer Services. See below for the full list of staging recommendations for each specialty. 

The updated TNM 9 staging appendices are now available accompanying the datasets below.

As of June 2026 there have been minor updates to SNOMED coding and terms for the datasets so for up to date codes please refer to the separate appendices rather than the dataset document itself.

Breast

 

Endocrine system

 

Eye

 

Gastrointestinal tract

Liver

 

 

 

Gynaecological tract

Head and neck

 

Lung and thorax

Tissue pathway for non-neoplastic thoracic pathology

October 2024

 

 

Skin

Invasive squamous cell carcinoma

 

 

Urinary tract and testis